Skip to main content

Table 1 Prescribed antiretroviral regimens

From: Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

Treatment regimens

Number

Percentage

AZT+3TC+NVP

53

45.69

d4T+3TC+NVP

48

41.38

FTC+TDF+EFV

13

11.21

ABC+3TC+EFV

1

0.86

ABC+3TC+EFV

1

0.86

Total

116

100

  1. ABC Abacavir, AZT Zidovudine, 3TC lamuvidine, EFV efavirenz, NVP nevirapine, d4T stavudine, TDF tenofovir, FTC emtricitabine
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us